Vergleich
3 Hydroxy 3 Methylglutaryl Coa Synthase Deficiency C2751532 vs. 3mc Syndrome 1 C0796059
Zwei seltene genetische Erkrankungen mit unterschiedlichem Schwerpunkt: ein Stoffwechseldefekt der Ketogenese/Energiebereitstellung aus Fetten versus ein pleiotropes kongenitales Fehlbildungssyndrom. Beide erfordern multidisziplinäre Betreuung, unterscheiden sich aber deutlich in Akutmanagement und Verlauf.
3 Hydroxy 3 Methylglutaryl Coa Synthase Deficiency C2751532
A metabolic disorder affecting the body's ability to produce energy from fats. Episodes of low blood sugar, vomiting, and metabolic crisis can occur, especially during fasting or illness. Dietary management and emergency protocols are essential.
3mc Syndrome 1 C0796059
A rare genetic disorder affecting multiple body systems, causing distinctive facial features, developmental delays, and growth issues. Management involves multidisciplinary care.
6 Vergleichsachsen
Onset
3 Hydroxy 3 Methylglutaryl Coa Synthase Deficiency C2751532
0-6
3mc Syndrome 1 C0796059
0-0
Onset patterns differ
Severity
3 Hydroxy 3 Methylglutaryl Coa Synthase Deficiency C2751532
severe
3mc Syndrome 1 C0796059
moderate
Different severity levels
Chronic
3 Hydroxy 3 Methylglutaryl Coa Synthase Deficiency C2751532
Chronic
3mc Syndrome 1 C0796059
Chronic
Differing course
Communicable
3 Hydroxy 3 Methylglutaryl Coa Synthase Deficiency C2751532
No
3mc Syndrome 1 C0796059
No
Different transmission
Body System
3 Hydroxy 3 Methylglutaryl Coa Synthase Deficiency C2751532
metabolic
3mc Syndrome 1 C0796059
congenital
Same/different system
Category
3 Hydroxy 3 Methylglutaryl Coa Synthase Deficiency C2751532
metabolic
3mc Syndrome 1 C0796059
genetic
Different category
Fazit
3-hydroxy-3-methylglutaryl-coa-synthase-deficiency-C2751532 and 3mc-syndrome-1-C0796059 differ in severity, etiology
Wichtigste Unterscheidungsmerkmale
Befunde, die die beiden Erkrankungen bei der Untersuchung oder in der Abklärung am zuverlässigsten trennen.
| Merkmal | 3 Hydroxy 3 Methylglutaryl Coa Synthase Deficiency C2751532 | 3mc Syndrome 1 C0796059 | Trennschärfe |
|---|---|---|---|
| Metabolic crisis | Vomiting and low blood sugar may occur during fasting or illness. | A fasting-related metabolic crisis is not the described hallmark. | High |
| Congenital appearance and growth | Distinctive facial features are not the defining presentation. | Distinctive facial features and growth issues are described. | High |
| Development | Developmental effects after crises are possible but not established here. | Developmental delay is a described feature. | Moderate |
Wann welche Erkrankung wahrscheinlicher ist
3 Hydroxy 3 Methylglutaryl Coa Synthase Deficiency C2751532 wählen, wenn
Vomiting with suspected low blood sugar during fasting or illness
This matches the described metabolic-crisis pattern.
High
Concern about impaired energy production from fats
The source specifically identifies disordered fat-derived energy metabolism.
High
Planning dietary precautions and emergency care
Dietary management and emergency protocols are emphasized.
Moderate
3mc Syndrome 1 C0796059 wählen, wenn
Congenital facial features with growth concerns
These are central features in the supplied description.
High
Early developmental delay
Developmental delay is explicitly described.
Moderate
Need for coordinated care across specialties
Management is described as multidisciplinary rather than crisis-focused.
Moderate
Wie sich zentrale Tests unterscheiden
| Test | 3 Hydroxy 3 Methylglutaryl Coa Synthase Deficiency C2751532 | 3mc Syndrome 1 C0796059 | Interpretation |
|---|---|---|---|
| Metabolic testing during illness | May show low blood sugar or related abnormalities; exact cutoffs are not established here. | Not expected to define the syndrome. | An abnormal result prompts evaluation but is not itself a diagnosis. |
| Genetic testing | May support HMG-CoA synthase deficiency when clinically appropriate. | May support 3MC syndrome 1 when features fit. | Results require clinical correlation and do not alone determine management. |
| Growth and developmental assessment | Secondary effects are possible; a defining pattern is not established. | Growth issues and developmental delay are important clinical clues. | Assessments guide referral but do not replace diagnostic confirmation. |
Prognosevergleich
3 Hydroxy 3 Methylglutaryl Coa Synthase Deficiency C2751532
- Verlauf
- Variabel und abhängig von frühzeitiger Erkennung und konsequenter Krisenprophylaxe
- Faktoren
- Frühe Diagnose, Ernährungsmanagement, Notfallprotokolle, Vermeidung von Fasten
3mc Syndrome 1 C0796059
- Verlauf
- Variabel; bestimmt durch Ausmaß der Fehlbildungen und Entwicklungsbeeinträchtigung
- Faktoren
- Schweregrad der Organbeteiligung, frühzeitige Förderung, multidisziplinäre Betreuung
Zeitraum: Lebenslange Betreuung und Verlaufskontrolle
Individuelle Ausprägung, Diagnosezeitpunkt, Verfügbarkeit spezialisierter Versorgung
Komplikationsvergleich
| Komplikation | Darstellung |
|---|---|
| Acute decompensation | Metabolic crisis with vomiting and low blood sugar may occur. Acute metabolic crisis is not described as characteristic. Emergency planning is important for the metabolic disorder. |
| Growth impairment | Possible, but not established as a defining complication. Growth issues are described. Growth should be monitored with clinician review. |
| Developmental impact | Impact after severe episodes is possible; frequency is unknown here. Developmental delay is a described feature. Early developmental support may be considered. |
Wichtige Punkte für die Patientenschulung
- HighFasting and illness
For HMG-CoA synthase deficiency, avoid prolonged fasting and follow the clinician’s illness plan.
- HighTransmission
Neither condition is communicable.
- MediumFollow-up
3MC syndrome 1 generally needs coordinated specialty care; metabolic treatment is individualized.